Peptide tags can act as molecular barcodes: their sequences record the steps used to make each small molecule in a pooled library. In a 2023 proof of concept, researchers used these tags with palladium-mediated chemistry, then used tandem mass spectrometry to identify protein-binding compounds selected from the libraries. The approach could broaden the chemistry available to encoded-library screening, but it has not produced a proven medicine.
What is a peptide-encoded library?
A peptide-encoded library (PEL) is a collection of small molecules, each paired with a peptide tag that carries information about how that molecule was made. The tag is an identifier, not the part intended to bind the screening target. A cleavable linker connects the tag to its small molecule so the two can be separated for analysis.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Drugs: From Discovery to Approval | $59.12 | Buy on Amazon |
| 2 |
|
Basic Principles of Drug Discovery and Development | $268.00 | Buy on Amazon |
| 3 |
|
Textbook of Drug Design and Discovery | $55.19 | Buy on Amazon |
| 4 |
|
Computational Drug Discovery and Design (Methods in Molecular Biology, 2714) | $139.46 | Buy on Amazon |
| 5 |
|
Drugs: From Discovery to Approval | $135.33 | Buy on Amazon |
As an Amazon Associate I earn from qualifying purchases.
The method adapts molecular barcoding to chemical synthesis. Rather than attach DNA to every library member, the researchers used chemically robust, abiotic peptides—peptides made with non-natural amino acids—as information carriers. The peptide sequence records the choices of building blocks and reactions in the molecule’s synthesis history.
Free tools Windows power users keep installed
One-click scans. No signup required.
How do the tags record and reveal a molecule’s identity?
Split, react and recombine
The study used solid-phase split-and-pool synthesis on polystyrene resin. Researchers divide resin-bound material into portions, react each portion with a different building block, and recombine the portions before the next synthesis step. Repeating this process creates many different compounds in one pooled library.
#1 Best Overall
At the same time, corresponding amino acids are added to the peptide tag in a defined order. Each addition records a synthesis decision. The small molecule and its tag therefore remain associated while the library is made and screened.
Separate the tag, then decode it
After affinity selection, the cleavable linker allows the tag to be separated from the small molecule for analysis. Tandem mass spectrometry (MS/MS) reads the peptide sequence; that sequence points back to the building blocks and reaction steps used to make the associated compound. The researchers used this information to identify selected molecules.
The reported design used 16 non-isobaric amino acids—units distinguishable by mass—as encoding symbols. An eight-position hexadecimal scheme provides a theoretical capacity of 4.3 billion possible codes. That is the code space, not the number of compounds synthesized, screened or shown to bind a target in the study.
What did the 2023 study demonstrate?
Simon L. Rössler, Nathalie M. Grob, Stephen L. Buchwald and Bradley L. Pentelute reported two peptide-encoded libraries in their March 2023 Science paper, “Abiotic peptides as carriers of information for the encoding of small molecule library synthesis” (volume 379, issue 6635, pages 939–945; DOI 10.1126/science.adf1354).
Rank #3
| Library | Reported size | Chemistry |
|---|---|---|
| C–N coupling library | About 41,000 members | C–N coupling |
| C–C coupling library | About 39,000 members | C–C coupling |
The team used affinity selection with three protein targets: carbonic anhydrase IX, BRD4(1) and MDM2. They then decoded selected tags by mass spectrometry to identify small-molecule ligands. The study’s result is de novo identification of protein-binding compounds from the encoded libraries; it does not establish that those compounds are medicines.
Why use peptide tags instead of DNA?
DNA-encoded libraries use DNA as the identifier and benefit from sensitive decoding. But the chemistry used to build a library must be compatible with the DNA tag. Some reaction conditions can be challenging for DNA. The peptide tags in this study tolerated palladium-mediated transformations, making it possible to use cross-coupling chemistry in the reported libraries.
That is a potential expansion of the encoded-library toolkit, not evidence that peptide tags are universally better or that DNA-encoded libraries are obsolete. The choice of platform depends on the chemistry and screening problem, as well as how reliably the tag can be decoded and whether it affects the selection.
Recommended Free Tools
| Comparison point | What the peptide-tag study shows | What remains important to assess |
|---|---|---|
| Reaction compatibility | The tags enabled the reported palladium-mediated coupling chemistry. | Compatibility depends on the reactions needed for a particular library; the study does not establish universal compatibility. |
| Library size and diversity | The two demonstrated libraries contained about 39,000 and 41,000 members. | Those are proof-of-concept libraries; size alone does not measure chemical diversity or screening quality. |
| Tag interference | The study paired the tag with the small molecule through a cleavable linker. | A diverse peptide-tag library could interfere with affinity selection, an issue identified in a 2023 technical review. |
| Decoding | MS/MS was used to read selected peptide tags and identify corresponding compounds. | Decoding sensitivity and reliability matter when applying the method at larger scale. |
| Meaning of a hit | Affinity selection yielded protein-binding ligands. | Binding alone does not establish functional activity, biological selectivity, therapeutic effect or safety. |
How far is this from a drug?
Affinity selection finds compounds that bind a target under the conditions of the screen. It does not show by itself that a compound changes the target’s function, works selectively in a biological system, has a therapeutic effect or is safe. The reported ligands are early discovery hits, not approved drugs, proven cancer treatments or established clinical candidates.
Best Value
The distinction matters for the three proteins used in the study. Naming a target associated with disease does not show that a selected binder will treat that disease. Further experiments would be needed to determine what a compound does in relevant biological systems and whether it has the properties required for a medicine.
What needs to improve before the approach scales?
A 2023 technical review of tandem-mass-spectrometry encoded libraries describes the PELs as relatively small and identifies larger libraries and possible interference from diverse peptide tags as issues for further work. Scaling therefore involves more than increasing the theoretical number of available codes: the chemistry must make useful compounds, selection must preserve meaningful binding information, and the tags must remain decodable.
- Build larger, useful libraries: The eight-position code capacity is not evidence that billions of compounds can currently be synthesized or screened with this method.
- Check for tag effects: The peptide and linker should not distort target binding or affinity selection in ways that obscure which small molecules are genuine hits.
- Validate hits beyond binding: Selected compounds need functional and biological testing before claims about therapeutic potential are justified.
The work establishes a practical proof of concept for using robust peptide tags to encode small-molecule synthesis, including chemistry that can challenge DNA-based tags. Whether PELs become a broadly useful drug-discovery platform will depend on expanding library scale while preserving reliable selection and decoding.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
